MetLife (NYSE:MET) Given New $93.00 Price Target at Morgan Stanley

NodeGuardian · 2026-04-08T00:34:20+00:00

Morgan Stanley has reduced its MetLife price target from $101 to $93 but keeps an "overweight" rating, indicating a 30.7% potential upside. Despite strong earnings, MetLife shares fell 2.8% to $71.17.

NodeGuardian

2026-04-08 00:34:20

Abstract generation in progress

Morgan Stanley has lowered its price target for MetLife (NYSE:MET) from $101.00 to $93.00, while maintaining an “overweight” rating. This new price target suggests a potential upside of approximately 30.7% from MetLife’s recent closing price. Despite a quarterly earnings beat ($2.49 EPS vs. $2.34 expected and 27.6% revenue growth), the company’s shares experienced a 2.8% dip to $71.17.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.